154 related articles for article (PubMed ID: 25083313)
1. Hypercalcemia from metastatic pancreatic neuroendocrine tumor secreting 1,25-dihydroxyvitamin D.
Zhu V; de Las Morenas A; Janicek M; Hartshorn K
J Gastrointest Oncol; 2014 Aug; 5(4):E84-7. PubMed ID: 25083313
[TBL] [Abstract][Full Text] [Related]
2. Case Report: Unmasking Hypercalcemia in Patients With Neuroendocrine Neoplasms. Experience From Six Italian Referral Centers.
Giannetta E; Sesti F; Modica R; Grossrubatscher EM; Guarnotta V; Ragni A; Zanata I; Colao A; Faggiano A
Front Endocrinol (Lausanne); 2021; 12():665698. PubMed ID: 34093441
[TBL] [Abstract][Full Text] [Related]
3. Hypercalcemia of malignancy caused by parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumors (PTHrP-PNETs): Case Report.
Pitts S; Mahipal A; Bajor D; Mohamed A
Front Oncol; 2023; 13():1197288. PubMed ID: 37377908
[TBL] [Abstract][Full Text] [Related]
4. Severe hypercalcemia due to metastatic pancreatic neuroendocrine tumor: a case report.
Behdadnia A; Jeddi M
J Med Case Rep; 2023 Sep; 17(1):400. PubMed ID: 37670372
[TBL] [Abstract][Full Text] [Related]
5. What Lies behind Paraneoplastic Hypercalcemia Secondary to Well-Differentiated Neuroendocrine Neoplasms? A Systematic Review of the Literature.
Giannetta E; Sesti F; Modica R; Grossrubatscher EM; Ragni A; Zanata I; Colao A; Faggiano A
J Pers Med; 2022 Sep; 12(10):. PubMed ID: 36294693
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic Neuroendocrine Tumor With Humoral Hypercalcemia and High Tumor PD-L1 Score.
Copur MS; Vargas L; Wedel W; Merani S; Cushman-Vokoun A; Drincic A
Oncology (Williston Park); 2020 Dec; 34(12):548-552. PubMed ID: 33395496
[TBL] [Abstract][Full Text] [Related]
7. Humoral hypercalcemia of malignancy caused by parathyroid hormone-related peptide-secreting neuroendocrine tumors. Report of six cases.
Milanesi A; Yu R; Wolin EM
Pancreatology; 2013; 13(3):324-6. PubMed ID: 23719609
[TBL] [Abstract][Full Text] [Related]
8. Peptide receptor radionuclide therapy controls inappropriate calcitriol secretion in a pancreatic neuro-endocrine tumor: a case report.
Haemels M; Delaunoit T; Van Laere K; Van Cutsem E; Verslype C; Deroose CM
BMC Gastroenterol; 2020 Oct; 20(1):324. PubMed ID: 33008295
[TBL] [Abstract][Full Text] [Related]
9. 1,25-dihydroxyvitamin D and PTHrP mediated malignant hypercalcemia in a seminoma.
Rodríguez-Gutiérrez R; Zapata-Rivera MA; Quintanilla-Flores DL; Camara-Lemarroy CR; Lavalle-Gonzalez FJ; González-González JG; Villarreal-Pérez JZ
BMC Endocr Disord; 2014 Apr; 14():32. PubMed ID: 24721620
[TBL] [Abstract][Full Text] [Related]
10. Recurrent hypercalcemia due to ectopic production of parathyroid hormone-related protein and intact parathyroid hormone in a single patient with multiple malignancies.
Eid W; Wheeler TM; Sharma MD
Endocr Pract; 2004; 10(2):125-8. PubMed ID: 15256329
[TBL] [Abstract][Full Text] [Related]
11. Humoral hypercalcemia associated with gastric carcinoma secreting parathyroid hormone: a case report and review of the literature.
Nakajima K; Tamai M; Okaniwa S; Nakamura Y; Kobayashi M; Niwa T; Horigome N; Ito N; Suzuki S; Nishio S; Komatsu M
Endocr J; 2013; 60(5):557-62. PubMed ID: 23303131
[TBL] [Abstract][Full Text] [Related]
12. [Hypercalcemia in malignancies of the female genital tract].
Piura B
Harefuah; 2008 Mar; 147(3):229-34, 277. PubMed ID: 18488865
[TBL] [Abstract][Full Text] [Related]
13. Persistent and moderate hypercalcemia related to an ovarian clear cell adenocarcinoma: Pre- and postoperative parathyroid hormone related-peptide and 1,25-dihydroxyvitamin D3 levels.
Benit A; Allard J; Rimailho J; Fauvel J; Escourrou G; Vezzosi D; Donadille F; Bennet A; Caron P
J Endocrinol Invest; 2006 May; 29(5):443-9. PubMed ID: 16794368
[TBL] [Abstract][Full Text] [Related]
14. Severe Hypercalcemia as the Initial Presentation of a Neuroendocrine Carcinoma of Unknown Primary Site: A Case Report.
Shaka H; Raghavan S
Cureus; 2019 Nov; 11(11):e6075. PubMed ID: 31832292
[TBL] [Abstract][Full Text] [Related]
15. Complete Tumor Resection for a Hepatocellular Carcinoma Secreting Parathyroid Hormone-related Peptide.
Kim EK; Kim JS; Shin KC; Lee GT; Han CJ; Kim SB; Ku YH
Korean J Gastroenterol; 2015 Aug; 66(2):122-6. PubMed ID: 26289247
[TBL] [Abstract][Full Text] [Related]
16. Plasma PTH and PTH-rP levels and clodronate therapy in cancer patients with hypercalcemia.
Su RJ; Chang CC; Tsai KS
J Formos Med Assoc; 1993 Nov; 92(11):977-82. PubMed ID: 7910069
[TBL] [Abstract][Full Text] [Related]
17. Case report of multimodality treatment for metastatic parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour.
Rossi RE; Naik K; Navalkissoor S; Imber C; O'Beirne J; Toumpanakis C; Caplin ME
Tumori; 2014; 100(4):153e-6e. PubMed ID: 25296608
[TBL] [Abstract][Full Text] [Related]
18. Ovarian non-small cell neuroendocrine carcinoma with paraneoplastic parathyroid hormone-related hypercalcemia.
Ohira S; Itoh K; Shiozawa T; Horiuchi A; Ono K; Takeuchi H; Hosoda W; Konishi I
Int J Gynecol Pathol; 2004 Oct; 23(4):393-7. PubMed ID: 15381910
[TBL] [Abstract][Full Text] [Related]
19. An unusual case of malignancy-related hypercalcemia.
Doyle MA; Malcolm JC
Int J Gen Med; 2013; 7():21-7. PubMed ID: 24353437
[TBL] [Abstract][Full Text] [Related]
20. Multifactorial hypercalcemia and literature review on primary hyperparathyroidism associated with lymphoma.
Maletkovic J; Isorena JP; Palma Diaz MF; Korenman SG; Yeh MW
Case Rep Endocrinol; 2014; 2014():893134. PubMed ID: 24716007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
